Vesper Hospice 6345 Balboa Blvd, Suite 210, Encino, CA, 91316 | |
(818) 881-9588 |
News Archive
Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.
The need for more research into the long-term health effects of electronic cigarettes has been highlighted by scientists in the British Medical Journal.
Colorado is taking a critical step to protect low-income women during their pregnancy through incentive-based smoking cessation interventions. A new study from the Colorado School of Public Health at the Anschutz Medical Campus shows a significant reduction in infant morbidity due to the program.
Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing of PREZISTA® (darunavir) tablets in combination with ritonavir for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients with no darunavir resistance-associated mutations (DRV RAMs).
› Verified 6 days ago
Name | Vesper Hospice |
---|---|
Location | 6345 Balboa Blvd, Suite 210, Encino, California |
Hospice ID | 551620 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 200 |
News Archive
Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.
The need for more research into the long-term health effects of electronic cigarettes has been highlighted by scientists in the British Medical Journal.
Colorado is taking a critical step to protect low-income women during their pregnancy through incentive-based smoking cessation interventions. A new study from the Colorado School of Public Health at the Anschutz Medical Campus shows a significant reduction in infant morbidity due to the program.
Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing of PREZISTA® (darunavir) tablets in combination with ritonavir for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients with no darunavir resistance-associated mutations (DRV RAMs).
› Verified 6 days ago
NPI Number | 1497090013 |
Organization Name | Vesper Healthcare, Inc. |
Address | 6345 Balboa Blvd Ste 210 Encino, California, 91316 |
Phone Number | (818)881-9855 |
News Archive
Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.
The need for more research into the long-term health effects of electronic cigarettes has been highlighted by scientists in the British Medical Journal.
Colorado is taking a critical step to protect low-income women during their pregnancy through incentive-based smoking cessation interventions. A new study from the Colorado School of Public Health at the Anschutz Medical Campus shows a significant reduction in infant morbidity due to the program.
Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing of PREZISTA® (darunavir) tablets in combination with ritonavir for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients with no darunavir resistance-associated mutations (DRV RAMs).
› Verified 6 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 82.1 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 94.9 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 83.3 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 95.7 | 97.3 |
Patients who got timely treatment for shortness of breath | 88.4 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 92.3 | 93.3 |
News Archive
Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.
The need for more research into the long-term health effects of electronic cigarettes has been highlighted by scientists in the British Medical Journal.
Colorado is taking a critical step to protect low-income women during their pregnancy through incentive-based smoking cessation interventions. A new study from the Colorado School of Public Health at the Anschutz Medical Campus shows a significant reduction in infant morbidity due to the program.
Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing of PREZISTA® (darunavir) tablets in combination with ritonavir for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients with no darunavir resistance-associated mutations (DRV RAMs).
› Verified 6 days ago
Home Health Aides | 2 |
Counselors | 1 |
Homemakers | 1 |
Licensed Practical or Vocational Nurses | 2 |
Medical Social Workers | 1 |
Physicians | 1 |
Registered Nurses | 3 |
Total Employees | 11 |
---|
News Archive
Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.
The need for more research into the long-term health effects of electronic cigarettes has been highlighted by scientists in the British Medical Journal.
Colorado is taking a critical step to protect low-income women during their pregnancy through incentive-based smoking cessation interventions. A new study from the Colorado School of Public Health at the Anschutz Medical Campus shows a significant reduction in infant morbidity due to the program.
Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing of PREZISTA® (darunavir) tablets in combination with ritonavir for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients with no darunavir resistance-associated mutations (DRV RAMs).
› Verified 6 days ago
Counselors | 2 |
Total Volunteers | 2 |
---|
News Archive
Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.
The need for more research into the long-term health effects of electronic cigarettes has been highlighted by scientists in the British Medical Journal.
Colorado is taking a critical step to protect low-income women during their pregnancy through incentive-based smoking cessation interventions. A new study from the Colorado School of Public Health at the Anschutz Medical Campus shows a significant reduction in infant morbidity due to the program.
Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing of PREZISTA® (darunavir) tablets in combination with ritonavir for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients with no darunavir resistance-associated mutations (DRV RAMs).
› Verified 6 days ago
Vitas Healthcare Corp Location: 16830 Ventura Blvd #315, Encino, California, 91436 Phone: (818) 881-9588 |
Skirball Hospice Location: 6345 Balboa Blvd., Suite 315, Encino, California, 91316 Phone: (818) 881-9588 |
Vesper Hospice Location: 6345 Balboa Blvd, Suite 210, Encino, California, 91316 Phone: (818) 881-9588 |
Community Hospice Care, Llc Location: 17141 Ventura Blvd, Suite 204, Encino, California, 91316 Phone: (818) 881-9588 |